Drug Master Files (DMF)
The following Drug Master Files (Type II) have been submitted to the U.S. Food and Drug Administration (FDA). Customers may reference these DMFs in their ANDA / NDA applications by submitting a Letter of Authorization (LOA) to the FDA.
| No. | Product Name | DMF No. | Status |
|---|---|---|---|
| 1 | Chlorzoxazone | 8736 | Active |
| 2 | Crotamiton | 26374 | Active |
| 3 | Diclofenac Epolamine | 24962 | Active |
| 4 | Diclofenac Sodium | 9899 | Active |
| 5 | Granisetron | 25980 | Active |
| 6 | Granisetron HCl | 26504 | Active |
| 7 | Lamotrigine | 030270 | Active |
| 8 | Metaxalone | 24631 | Active |
| 9 | Naftopidil | 26502 | Active |
| 10 | Phenylephrine HCl | 18319 | Active |
| 11 | Pramoxine HCl | 15464 | Active |
| 12 | Riluzole | 26147 | Active |
| 13 | Rizatriptan Benzoate | 28634 | Active |
| 14 | Sodium Stearyl Fumarate | 18189 | Active |
| 15 | Timolol Maleate | 036428 | Active |
| 16 | Tolperisone HCl | 25466 | Active |
| 17 | Zolmitriptan | 27818 | Active |
The following Master Files have been filed with the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan. Customers may cross-reference these files when applying for manufacturing and marketing approval in Japan.
| No. | Product Name | MF No. | Status |
|---|---|---|---|
| 1 | Atomoxetine HCl | 229MF10113 | Active |
| 2 | Crotamiton | 228MF10116 | Active |
| 3 | Eperisone HCl | 221MF10236 | Active |
| 4 | Lansoprazole | 302MF10112 | Active |
| 5 | Lamotrigine | 228MF10086 | Active |
| 6 | Naftopidil | 225MF10172 | Active |
| 7 | Naftopidil | 229MF10072 | Active |
| 8 | Oxazolam | 224MF10023 | Active |
| 9 | Oxethazaine | 223MF10076 | Active |
| 10 | Rabeprazole Sodium | 226MF10145 | Active |
| 11 | Rizatriptan Benzoate | 227MF10229 | Active |
| 12 | Timolol Maleate | 225MF10066 | Active |
| 13 | Tolvaptan | 302MF10031 | Active |
| 14 | Zolmitriptan | 226MF10060 | Active |
| 15 | Dimemorfan Phosphate | 306MF10070 | Active |
SYN-TECH has obtained CEP certificates (Certificate of Suitability to the Monographs of the European Pharmacopoeia) and filed registrations in multiple countries. Contact our sales team for Letter of Authorization (LOA) requests.
| No. | Product Name | Certificate / File No. | Applicant |
|---|---|---|---|
| European Union — CEP (Certificate of Suitability, EDQM) | |||
| 1 | Crotamiton | R1-CEP 2014-260-Rev 01 | EDQM |
| 2 | Phenylephrine HCl | R1-CEP 2006-231-Rev 01 | EDQM |
| 3 | Sodium Stearyl Fumarate | CEP 2011-269-Rev 02 | EDQM |
| Germany | |||
| 1 | Tolperisone HCl | 1059 | BfArM |
| Korea — Drug Master File (MFDS) | |||
| 1 | Cloperastine HCl | 2021-A1-1502 | MFDS |
| 2 | Diclofenac Sodium | 20071025-80-D-8-02 | MFDS |
| 3 | Timolol Maleate | 20130418-201-I-226-06 | MFDS |
| 4 | Naftopidil | 6580-17-ND | MFDS |
| 5 | Phenylephrine HCl | 20071025-88-D-17-02 | MFDS |
| China — Drug Master File (NMPA) | |||
| 1 | Crotamiton | Y20200001167 | NMPA |
| 2 | Crotamiton | F20190000650 | NMPA |
| 3 | Atomoxetine HCl | Y20210000399 | NMPA |
| 4 | Sodium Stearyl Fumarate | F20180000204 | NMPA |
| Australia — Drug Master File (TGA) | |||
| 1 | Prazosin HCl | E007477 | TGA |